Branch
Wednesday, May 09th 2018
Imperial College London, Sir Alexander Fleming Building, Lecture Theatre G16, London, SW7 2AZ
17:45 – 22:30 (GMT)
Do you want to attend? Get your ticket!
Register NowDigital healthcare scene is already on a roll in the US and is booming in Europe as well.
Innovation Forum Imperial recognises the rising of a digital healthcare industry in the U.K. and globally, and there are ambitious plans developing for the transformation of healthcare industry. We would like to provide a platform for the stakeholders from academia, policymakers, and private sectors to discuss and provide insights, and to promote collaborations and sustain improvements across the digital healthcare ecosystem. In collaboration with Imperial Enterprise lab, Innovation Forum presents everyone from any background an opportunity to gain bite-sized updates and insights into digital healthcare scene.
The event will consist of a series of short talks followed by a panel discussion and a networking session. 7 speakers have been selected to provide a landscape of digital healthcare from different perspectives, including academia, start-ups and investors. Food and drinks will be provided during the networking session.
Registration
Welcome Remarks
Jaysze Yong,
President, Innovation Forum Imperial
Commencement of First Session
Digital Healthcare Innovation – high quality and affordable at the point of care
Dr Eduardo Aguilar Pelaez,
Head of Technology, Imperial Helix Centre
AI: The Future of Healthcare?
Prof Paul Leeson,
Professor of Cardiovascular Medicine, Head of Oxford Cardiovascular Clinical Research Facility, University of Oxford,
CMO, Non-Executive Director, Academic Founder, ULTROMICS
The Role of Big Data Analysis in Healthcare
Nicolaus Henke,
Senior Partner, McKinsey & Company
Global Leader, McKinsey Analytics
Chairman, QuantumBlack
Making Innovation happen in the NHS – Progress and Learning from Chelsea and Westminster NHS and its Charity CW+
Dr Lawrence Petalidis,
Chair, digital healthcare advisory board, Head of Innovation, CW+,
Chelsea and Westminster Hospital NHS foundation Trust
Roundtable for First Session
Short Break with Coffee and Tea
Commencement of Second Session
Ultimate Guide to Ace in the Ecosystem of Digital Healthcare
Hak Salih,
Digital Health Lead, MedCity
The Story of A Successful Digital Healthcare Startup
Dr Isabel Van De Keere,
Founder, CEO, Immersive Rehab
Hacking corporate culture
Dr Ulf Hengstman,
IT Product Manager, Bayer
Roundtable for Second Session
Closing Remarks
Networking with Complementary Food / Drinks
Jaysze Yong is a final year PhD candidate at Imperial College London, jointly funded by Department of Surgery and Cancer, Imperial College and the International Imperial College PhD programme. Her PhD focuses on molecular oncology, specifically on epigenetics, transcription factor profiles, gene expression analysis to investigate signalling pathways leading to breast cancer development and drug resistance.
Prior to the PhD, Jaysze completed MRes with distinction at Imperial College London in cancer biology. She currently works at Innovation Forum Imperial College London as the President.
Dr Eduardo Aguilar Pelaez's career has spanned academia, startups and global companies in the technology space. As Head of Technology at Helix, he guides the engineering roadmap, and works with the designers and clinicians to bring innovations to life. Prior to Helix, he was a Product Manager at onefinestay, covering mobile, enterprise software and IoT systems, including the Sherlock smart lock product (now klevio.com). Prior to that, he worked on high performance computing, and earlier was a co-founder of Ervitech, a medical technology company focused on a miniature wearable breathing monitor based on his PhD research. Eduardo also worked at CERN on the Beam Conditions Monitor as part of the ATLAS and LHC's safety systems.
Prof Paul Leeson is Professor of Cardiovascular Medicine at the University of Oxford and a Consultant Cardiologist at the John Radcliffe Hospital in Oxford. He is also Head of the Oxford Cardiovascular Clinical Research Facility and leads a research group that combines machine learning with cardiovascular imaging to identify novel biomarkers of early disease.The findings are being turned into software applications for use in the clinic by the University of Oxford spin out, Ultromics.
Nicolaus is the global leader of McKinsey Analytics and chairman of QuantumBlack, an advanced-analytics firm operating at the intersection of strategy, technology, and design.
Guiding a team of more than 3,000 data scientists, platform engineers, and analytics consultants, Nicolaus oversees our efforts to bring insights from big data and advanced analytics into our advisory work. This often involves working with clients to evaluate strategic moves, foster operational transformations, and build capabilities to capture opportunities from data and analytics. He also enhances our ability to deliver distinctive analytics-based consulting by pursuing investments in talent and technology and establishing new strategic partnerships.
Nicolaus’ passion for analytics was largely inspired by his work serving institutions in the healthcare sector. As the leader of our global Healthcare Systems & Services Practice for more than a decade, he saw firsthand the potential for data analytics to improve the quality of management and strategic decision making. Working with more than 50 health systems around the world, he led efforts to pursue analytics-based opportunities such as the potential to integrate care by using population-oriented delivery models.
Strongly interested in discussion and debate, Nicolaus frequently offers his perspectives on the future of healthcare, data, and analytics at events hosted by Forbes, the Milken Institute, the World Economic Forum, and other institutions. He also convenes private gatherings of executives to network and share their insights on big data and healthcare topics.
Beyond his client advisory work, Nicolaus serves on the board of Innovations in Healthcare at Duke Medicine, an organization that he helped found, and on the dean's advisory council at Harvard’s Kennedy School. He holds a master’s in public administration from Harvard, where he was a John J. McCloy scholar.
Head of Innovation and impact, Cambridge bioscience PhD, with 12 years of commercial, transformation, project and business management experience. Navigator for the Digital Health.London Accelerator. London Microsoft Accelerator partner, NICE specialist advisor and Digital Health Advisor for West London CCG. Enabler of NHS digital health innovation, working with clinicians, technologists and businesses to transform patient care and health service efficiency. Manages a NHS Charity Grants programme supporting NHS clinical innovation champions and digital health transformation.
Digital Health Lead - Experienced investor focused on innovation and disruptive technologies across the board with a focus on healthcare. Focused on supporting start ups, early stage ventures and SMEs with product, target market, growth and financing plan assessments.
Love to help clients develop business strategy and plans, solve business problems, make their systems and processes work more efficiently and grow their businesses through changes that do not add to costs.
Award winning mentor, pro bono to small businesses and start-ups in the private and not for profit sectors - always willing to have a coffee and see if I can help you achieve your ambitions. If you want to connect please let me know why - that's how I manage my bandwidth!
Studied emerging disruptive technologies across many industries, including the coming impact within financial services (FinTech), Healthcare (MedTech), Robotics, Drones, 3D printing and Self Driving Cars.
Experienced financial analyst/investment manager – deep analytical skills focused on understanding business drivers, returns and cashflows with a strong stock picking track record across sectors.
Presenter, panellist and judge at various entrepreneurial events such as Delving into Digital, Association of Medical Research Charities Feb 2017, Panel host for Digital Health evening at Deep Science Ventures, Think Start Up conference May 2016, Milton Keynes, Panel Judge for Best R&D Product AXA PPP HealthTech & You Awards 2014.
Dr Isabel Van De Keere is the Founder & CEO of Immersive Rehab, a Virtual Reality digital health startup that focuses on the creation and development of physical & neuro-rehabilitation programmes in Virtual Reality that improve patient recovery. The goal is to increase the effectiveness of physical & neuro-rehabilitation, to reduce referral times, to make rehab fun and engaging, and to have a better patient outcome. Following a long physical rehab period Isabel went through herself due to a work accident, she decided to start Immersive Rehab in September 2016. With an MSc degree in Electro-Mechanical Engineering and as a Doctor in Biomedical Engineering, Isabel is passionate about healthcare technologies, digital health, immersive technologies (VR/AR) and its applications in healthcare, using tech for good, social entrepreneurship, and promoting women in tech.
Addicted to Digital Transformation with 30 years experience in Biology, Genomics, Market Intelligence, IT portfolio, product, program, project and line management. Ulf got his PHD in Microbiology at the Max-Planck-Institute for terrestrial Microbiology Marburg. After postdoc awardee his business stations where the Georg Thieme Verlag, Stuttgart and the Bertelsmann AG (Lycos Europe GmbH) before he joined Bayer in 2002. Since 2015 he is Digital Innovation Manager, supporting Bayer’s path in Digital Transformation. He enjoys mountain- and racing-biking, soccer and guitar playing.
Wednesday, May 09th 2018
17:45 – 22:30 (GMT)
Imperial College London, Sir Alexander Fleming Building, Lecture Theatre G16, London, SW7 2AZ
Request sponsorship opportunities package
Sponsor this event